Landscape Capital Management L.L.C. Boosts Stock Holdings in The Chemours Company $CC

Landscape Capital Management L.L.C. boosted its stake in shares of The Chemours Company (NYSE:CC) by 31.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 133,428 shares of the specialty chemicals company’s stock after acquiring an additional 31,639 shares during the period. Landscape Capital Management L.L.C.’s holdings in Chemours were worth $1,573,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Chemours by 2.8% during the fourth quarter. Vanguard Group Inc. now owns 17,920,868 shares of the specialty chemicals company’s stock valued at $211,287,000 after acquiring an additional 490,778 shares in the last quarter. State Street Corp lifted its position in Chemours by 22.7% during the second quarter. State Street Corp now owns 6,114,328 shares of the specialty chemicals company’s stock valued at $70,009,000 after purchasing an additional 1,131,682 shares during the last quarter. Ameriprise Financial Inc. lifted its position in Chemours by 13.8% during the third quarter. Ameriprise Financial Inc. now owns 4,796,153 shares of the specialty chemicals company’s stock valued at $75,971,000 after purchasing an additional 580,089 shares during the last quarter. UBS Group AG lifted its position in Chemours by 0.3% during the third quarter. UBS Group AG now owns 4,754,492 shares of the specialty chemicals company’s stock valued at $75,311,000 after purchasing an additional 14,865 shares during the last quarter. Finally, Cooper Creek Partners Management LLC bought a new position in Chemours during the third quarter valued at $63,103,000. 76.26% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CC has been the subject of several research reports. Morgan Stanley increased their price objective on shares of Chemours from $17.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, May 11th. JPMorgan Chase & Co. increased their price objective on shares of Chemours from $17.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, May 21st. BMO Capital Markets lowered their price objective on shares of Chemours from $20.00 to $19.00 and set an “outperform” rating for the company in a research report on Monday, February 23rd. Zacks Research upgraded shares of Chemours from a “strong sell” rating to a “hold” rating in a research report on Friday, April 24th. Finally, Truist Financial increased their price objective on shares of Chemours from $27.00 to $30.00 and gave the company a “buy” rating in a research report on Tuesday, April 28th. Six analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $24.60.

Chemours Price Performance

Chemours stock opened at $22.40 on Tuesday. The firm has a 50-day moving average price of $23.07 and a 200-day moving average price of $18.49. The firm has a market capitalization of $3.37 billion, a PE ratio of -8.48 and a beta of 1.40. The company has a current ratio of 1.82, a quick ratio of 0.87 and a debt-to-equity ratio of 18.98. The Chemours Company has a 12-month low of $10.14 and a 12-month high of $28.67.

Chemours (NYSE:CC) last released its earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.10. The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.40 billion. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The business’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the business earned $0.13 EPS. As a group, equities research analysts forecast that The Chemours Company will post 1.07 EPS for the current year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Sunday, May 17th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Friday, May 15th. Chemours’s dividend payout ratio (DPR) is -13.26%.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.